Valeant Pharmaceuticals reported $2.05B in Sales Revenues for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Amgen AMGN:US USD 6.84B 187M
Ani Pharmaceuticals ANIP:US USD 94.23M 10.41M
Aurora Cannabis Inc ACB:CN CAD 61.68M 12.42M
Biogen BIIB:US USD 2.54B 35.5M
Bristol Myers Squibb BMY:US USD 11.41B 188M
Canopy Growth Corp WEED:CN CAD 101.21M 16.65M
Catalent CTLT:US USD 1.15B 127M
Danaher DHR:US USD 8.37B 706M
Drreddys Laboratories RDY:US INR 67.7B 4.64B
Eli Lilly And LLY:US USD 7.3B 360.2M
Endo International Ordinary Shares ENDP:US USD 541.69M 27.42M
Gilead Sciences GILD:US USD 7.39B 347M
Lannett LCI:US USD 80.89M 5.82M
Prestige Brands PBH:US USD 275.52M 13.75M
Vertex Pharmaceuticals VRTX:US USD 2.3B 31.6M
Zoetis ZTS:US USD 2.04B 38M